Skip to main content

Military Health System

Partnerships, COVID-19 are catalysts for enterprise virtual health

Image of Mr. Adler with text: "Partnerships, COVID-19 are catalysts for enterprise virtual health.". Jamie Adler is the lead for the DHA’s Virtual Health Clinical Integration Office, part of the DHA Connected Health Branch, under DHA Medical Affairs. (Graphic courtesy of DHA Connected Health.)

Recommended Content:

Coronavirus & the MHS Response | Health Care Technology | Coronavirus and the COVID-19 Vaccine

In the pre-COVID-19 world, nearly all health care was delivered in person within brick-and-mortar facilities. Telehealth, referred to in the Department of Defense as virtual health or VH, was a promise of the future—a capability whose time had not quite yet arrived. VH, in those pre-pandemic days, and years, was relegated to pilot demonstrations and to specific specialties such as behavioral health delivered in limited settings.

As with so many other things, the COVID-19 pandemic wiped away long-held health care delivery practices and assumptions. Questions stopped being about if or even when VH would “take off” and started to be about how to maximize VH’s scope and reach in as short of a timeframe as possible. Mirroring the rest of the health care field, DOD rapidly scaled up VH capabilities, guidance, training, procedures, and provider and beneficiary communication and education. Over a period of weeks, the result was a multi-fold increase in overall VH capacity that supported basic clinical services across the DOD enterprise.

From a VH perspective, the pre-COVID-19 world is likely gone. VH as a core health care capability is here to stay. The Military Health System’ path forward can build upon COVID-19 and pre-existing efforts to develop enterprise VH capabilities that connect service members and their families to optimal health care—wherever and whenever it is needed.

To achieve this goal, it is important to realize that VH is not a single technology or business platform, or even group of platforms. Rather, it is about people, processes, and technologies working together across the entire MHS to create health care access solutions on behalf of our 9.6 million beneficiaries around the world.

The MHS is leveraging the experiences and workflows developed rapidly in response to COVID-19 to catalyze transformational change in enterprise use of VH. Coordination among multiple key stakeholders is essential and already underway to develop sustainable solutions that meet real MHS-wide needs.

These stakeholders include:

  • The newly emerging Defense Health Agency markets—regional clusters of MHS military medical treatment facilities
  • An enterprise-wide Virtual Medical Center
  • A variety of DHA headquarters offices, including the DHA Connected Health Branch’s Virtual Health Clinical Integration Office
  • The TRICARE private sector care network
  • The military services and interagency partners such as the Department of Veterans Affairs

Many Systems into One

For years, service-based enterprise and regional health care leaders and military medical treatment facilities (MTFs) spearheaded individual initiatives that built useful VH capabilities in a number of locations across the MHS. This approach, however, resulted in fragmented availability of VH capabilities across the more than 700 MTFs constituting the MHS. In addition, the TRICARE private sector care network permitted VH care only under limited circumstances.

In the 2017 National Defense Authorization Act, Congress required the DOD to expand VH across a wide spectrum of services and specialties, and across all direct (MTF-based) care and private sector care networks. Furthermore, Congress required that this VH expansion occur within the context of a consolidation and unification of non-deployed health care under the DHA. Since then, the DHA, the services, and their stakeholders have been working to prioritize, fund, and deliver integrated enterprise VH capabilities to medical centers and clinics, patient locations in the community, and settings in the field.

These efforts have one goal: create an integrated, comprehensive, high-quality, and reliable VH capability that reaches from forward deployment to fixed medical facilities, community settings, and to DOD partners such as the VA. The effect of the COVID-19 pandemic, as profound as it has been, was to greatly accelerate a process of enterprise VH expansion that is already ongoing.

Success of this endeavor would provide field units, clinics, inpatient facilities, managed care network providers, and virtual providers with the flexibility to meet patient needs regardless of location, while leveraging enterprise-wide competency, technical, procedural, and quality standards. This capability will turn VH into a powerful force multiplier for the MHS, delivering great health outcomes, support for a ready medical force, and enhanced beneficiary satisfaction. By increasing provider and support staff reach, capability, and effectiveness, VH will also help with the DHA’s goal of a fulfilled staff.

Looking Ahead

The COVID-19 pandemic is still testing MHS’ ability to use existing tools, training, and procedures to mount an aggressively accelerated deployment of VH capabilities. As we envision post-pandemic growth of virtual health, the MHS will need to continue to expand VH capabilities across its enterprise, while planning for the comprehensive and integrated tools and approaches that will make such growth sustainable in the long term.

Fielding any technology-based capability—including virtual health—takes a lot of pre-planning, collaboration, and effort. The development, acquisition, and sustainment of VH platforms across the MHS enterprise is an especially complex undertaking.

The MHS has many requirements beyond those followed by the non-DOD health care industry. In addition to providing safe, convenient, quality services, MHS VH must support military readiness and deployed health care, while operating within an environment of enhanced government regulation and heightened security. Meeting these requirements necessitates planning for all appropriate contingencies, including natural and man-made disasters and global emergencies such as the COVID-19 pandemic.

The results of these efforts, on the part of the MHS and its partners will be a virtual health capability that provides universal and global access to high-quality care and consultation to all beneficiaries, regardless of location or circumstance. This future state will be worth the effort for providers, and most importantly for patients, during the COVID-19 pandemic and beyond.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Waiver of Restrictive Licensure and Privileging Procedures to Facilitate the Expansion of Telemedicine Services in the Military Health System 12-010

Policy

In order to facilitate the expansion of telemedicine services in the Military Health System, this memorandum waives selective provisions of Department of Defense 602S.13-R, "Clinical Quality Assurance in the Military Health System," June 11 , 2004. This waiver is conditioned on the specific provisions of this memorandum, and shall remain in effect, unless modified or revoked, until the cancellation and reissuance of DoD 602S.13-R, or the issuance of a Department of Defense Instruction for or including telemedicine.

MHS Enterprise Architecture Signed Memo and Guide 20120730

Policy

Announcement of the release of the Military Health System (MHS) Enterprise Architecture (EA) Guide. The guide supports the MHS CIO’s responsibilities for development and maintenance of EA, which complies with the Department of Defense’s responsibilities under the Clinger-Cohen Act of 1996, Public Law 104-106.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2
Refine your search
Last Updated: December 27, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery